After teasing a plasma-based manufacturing expansion in the U.S. late last year, CSL is putting in the work and firming up details behind the $1.5-billion project. | On Monday, CSL broke ground on an ...
CSL’s new Illinois investment adds to over $3B spent on U.S. operations since 2018. The expansion will create at least 300 ...
New $1.5 billion investment builds on over $3 billion already spent on CSL's U.S. operations since 2018Expansion will create at least 300 new jobs and ...
The Kanakee project builds on the biopharma company’s efforts to increase its U.S. footprint, where it has already spent more than $3 billion, and will focus on producing plasma-derived therapies.
Australian biopharmaceutical company CSL announced Monday a major expansion at its Kankakee manufacturing facility, a move that will bring end-to-end plasma processing into the U.S.
Stockhead on MSN
Health Check: Telix jumps first hurdle with its advanced prostate cancer therapy trial
In welcome good news, Telix says the first stage of its pivotal prostate cancer therapeutic trial has hit its desired safety ...
The best part of this “scheme” is that it requires no capital to get started. You can begin by selling items you have lying around the house, which is a great way to declutter while making some money.
The third day of testimony begins Wednesday morning as prosecutors continue building their case against Ibraheem Yazeed in the 2019 killing of Aniah Blanchard.
The global biotechnology company announced minutes before the market closed on Tuesday that Mr McKenzie would be immediately replaced by Gordon Naylor, a current CSL director who has held a number of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results